We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effects of Patient Features on Opioid Induced End-Tidal CO2 (Capno)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01371903
First Posted: June 13, 2011
Last Update Posted: March 24, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Wayne Triner, Albany Medical College
June 10, 2011
June 13, 2011
March 24, 2014
August 2010
November 2012   (Final data collection date for primary outcome measure)
end tidal carbon dioxide [ Time Frame: study start, 30 minutes, 60 minutes, 90 minutes, 120 minutes ]
measured through small nasal cannula (plastic tube at base of nares)
Not Provided
Complete list of historical versions of study NCT01371903 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
The Effects of Patient Features on Opioid Induced End-Tidal CO2
The Effect of Patient Features on Opioid Induced End-Tidal CO2
Emergency department patients receiving opioid pain medicine such as morphine, fentanyl or Dilaudid are eligible. After medication exhaled carbon dioxide is measured. and recorded.
Emergency department patients receiving opioid pain medicine such as morphine, fentanyl, or Dilaudid are eligible. After receiving the pain medication, a small soft plastic tube will be placed between the upper lip and nose. This tube is used to measure the amount of carbon dioxide the patient is breathing out. It can also be used to deliver oxygen if the provider feels the patient needs it. The carbon dioxide breathed out is measured and collected. Other information collected are height, weight, and vital signs. Patient participation time is approximately 2 hours during the emergency department visit.
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Patients receiving opioid such as morphine, fentanyl, or dilaudid during their emergency department visit.
Opioid Use During Medical Care
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
278
November 2012
November 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • non intubated patients receiving intravenous opioid medications

Exclusion Criteria:

  • mechanically ventilated patients
  • patients with physiologic shock
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01371903
2792
Yes
Not Provided
Not Provided
Wayne Triner, Albany Medical College
Albany Medical College
Not Provided
Not Provided
Albany Medical College
June 2011